Control | Intervention 1 | Intervention 2 | p-value | |
---|---|---|---|---|
N | 76 | 77 | 83 | -- |
Male | 68.4% | 77.9% | 75.9% | 0.367 |
Age | 56.1 + 8.7 | 57.0 + 7.8 | 56.3 + 8.2 | 0.940 |
Internal Medicine | 54.0% | 61.0% | 51.8% | 0.475 |
Practice Type | ||||
Hospital-Based | 9.2% | 11.7% | 12.1% | 0.266 |
Private, Multi-Specialty | 34.2% | 32.5% | 20.5% | |
Private, Single Specialty | 30.3% | 29.9% | 45.8% | |
Private, Solo | 26.3% | 26.0% | 21.7% | |
Region* | ||||
Northeast | 33.3% | 24.7% | 28.9% | 0.829 |
South | 28.0% | 32.5% | 33.7% | |
Midwest | 21.3% | 20.8% | 22.9% | |
West | 17.3% | 22.1% | 14.5% | |
Setting* | ||||
Urban | 28.0% | 37.7% | 25.3% | 0.248 |
Suburban | 61.3% | 54.6% | 57.8% | |
Rural | 10.7% | 7.8% | 16.9% | |
Employed by Practice* | 82.7% | 77.9% | 69.9% | 0.157 |
Payer, % | ||||
Medicare | 37.7% | 34.5% | 36.5% | 0.654 |
Medicaid | 10.2% | 8.7% | 9.1% | 0.571 |
Commercial | 45.0% | 49.7% | 48.8% | 0.823 |
Self | 4.5% | 5.0% | 6.4% | 0.252 |
Other | 2.7% | 2.0% | 2.2% | 0.730 |
Participant in CMS Quality Program* | ||||
Yes | 30.7% | 31.2% | 41.0% | 0.356 |
No | 52.0% | 58.4% | 44.6% | |
Don’t know | 17.3% | 10.4% | 14.5% | |
Medication Reconciliation Used | ||||
Pharmacy reconciliation | 90.8% | 89.6% | 88.0% | 0.843 |
EMR alert | 85.5% | 80.5% | 75.9% | 0.310 |
Self-report | 67.1% | 68.8% | 73.5% | 0.659 |
Urine drug screen | 35.5% | 32.5% | 37.4% | 0.809 |
Confirmation drug testing | 19.7% | 15.6% | 25.3% | 0.308 |
Digital pills | 2.6% | 1.3% | 1.2% | 0.744 |
None | 0.0% | 0.0% | 2.4% | 0.156 |